Primeadine
Primeadine

Neurotech2020: It’s a brave new world

It’s an online conference, but not as you know it. Say goodbye to Zoom fatigue and hello to Neurotech2020.

Understanding the brain, consciousness and thought processes; protect them from the ravages of aging, age-related diseases and maybe even death. We’re working with our friends at neurotech.com to assemble the finest minds to share and discuss (and brainstorm) the neurotech state of play and what’s coming next.

Longevity.Technology: When you do something that’s incredibly full-on, there’s a period afterwards when you think: “Never again!”.  However, a couple of months later you remember the buzz, the energy, how much everyone got out of it, and you have a brainwave: “Actually, that was fab … we should do it again, but switch-it-up.”

Well, with Longevity2021 firmly in next year, we are delighted to announce Neurotech2020: a series of presentations, round tables, live demos and after hours events that put neurotech front and centre. Coffee? Make mine a double … it’s running over 2 weeks (yep).

 

 

The Longevity.Technology team has joined forces with Alon Braun, a business architect, who is skilled at helping ideas grow into products, something that is vital in the Longevity and Neurotech sectors. Together with Dmitry Kaminskiy, he founded neurotech.com and Braun is clear on the importance of neurotech and its ability “to bring big money into Longevity.”

Running over a two-week period from 30 November – 11 December Neurotech2020 will take the format of online lab demos and presentations, with opportunities to network with the speakers in breakout sessions.

Dave Asprey: he’ll be there talking 40 Years of Zen

Our stellar line-up of speakers already includes Dave Asprey, Sergey Young, Max Newlon of BrainCo, and Shawn Watson of Senescence Life Sciences with more big-hitters being added all the time.

During Neurotech2020, leaders from around the world will address these key neurotech growth subjects:

Consumer tech

Consumer Tech – launching on Cyber Monday
Neuro-gaming, biohacking and new devices, wearables, surface stimulation, bio-feedback, HRV/EMG, nootropics, neurofeedback, EEG.

First Longevity

 

Research
Neuroimaging, treatments for Alzheimer’s and cognitive disorders, conquering paralysis, neuromodulation, neuroethics, BCI (brain computer interfaces).


 

Clinical

Clinical
Neuroceuticals, electroceuticals, GABA, dopamine, serotonin, behavioural neuropharmacology, new modalities in epilepsy, next-generation psychiatry, spinal cord stimulation.


 

Longevity

Longevity
Neurological biomarkers, cognitive assessment, overcoming the obstacles of brain-computer interfacing, diagnostic medicine, singularity, neuroprotection, ethical analysis, neuroethics and the social impact of brain machine interface, neuroprosthetics, the role of machine learning, neuroergonomics – neurotech for every day.


 

Investment

Investment
Start-up pitch events, investment sessions, surviving the times, investor panel and start ups, neurotech IPOs/success stories, industry, industry groups.


 

“As we are shaping this conference, we are looking for speakers that have interesting technologies or new visions and bringing a variety of different perspectives together,” says Braun. “Neurotech is how we change humanity, how we improve humanity. All the things that I’m seeing as we plan it out – it will blow your mind!”

Buy tickets for the conference, or apply to speak.

First Longevity
Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of Crowd Longevity a digital investment platform for international investors and Longevity start-ups launching in 2020.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
Primeadine
lumen
Primeadine
lumen

Latest articles

Senescence: a new weapon in the fight against cancer

Targeting senescent “zombie” cells may improve cancer survival rates. How well women with cervical cancer respond to treatment (and survive) correlates with the level of...

Wearables and AI on the frontline of Longevity

Disruptive platforms are set for huge growth ahead of the inevitable consolidation and acquisitions: the race is on. Rise and fall used to be the...

The time is right for specialist Longevity investment

We speak to the co-founder of LongeVC – an investment firm focused exclusively on Longevity. Earlier this month, LongeVC emerged onto the scene with a...

Would you invest $1000 per week to live longer?

Money can't buy happiness - but it can buy Longevity;  this updated report from UBS identifies that investors are re-thinking where they invest their...